Trials
Search / Trial NCT05638724

Munich Long COVID Registry for Children, Adolescents, and Adults

Launched by TECHNICAL UNIVERSITY OF MUNICH · Dec 5, 2022

Trial Information

Current as of January 14, 2025

Recruiting

Keywords

Long Covid Post Covid Me/Cfs Cfs/Me Sars Co V 2 Covid 19

ClinConnect Summary

The Munich Long COVID Registry for Children, Adolescents, and Adults is a research study aimed at understanding the long-term effects of COVID-19, known as Post-COVID Condition (PCC), in people of all ages in Germany. Researchers want to gather information on how this condition affects individuals, how it develops over time, and what kind of healthcare support is needed. This data will help inform future clinical trials and improve treatment options for those dealing with Long COVID.

To participate in this study, individuals need to provide written consent, and they must have either received a COVID-19 vaccine or tested positive for the virus through a PCR or rapid antigen test. Other eligibility criteria include having specific medical codes that indicate suspected post-COVID conditions. Participants can expect to share their health information and experiences related to Long COVID, which will contribute to a better understanding of this condition and help others in the future. Please note that pregnant individuals and those with other health issues that explain their symptoms won't be eligible for this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • I. Written informed consent of the patient or legal guardian.
  • II. Confirmed SARS-CoV-2 vaccination and/or confirmed or probable SARS-CoV-2 infection: Positive SARS-CoV-2 polymerase chain reaction (PCR) or rapid antigen test (AST), documented probable COVID-19 (e.g., typical CT scan), probable COVID-19 with a history of high-risk contact, anti-SARS-CoV-2-N antibodies (and/or in non-vaccinated people -S-IgG antibodies) following probable COVID-19.
  • III. Additional ICD-10 codes: U09.9!V: Suspected post-COVID-19 condition, unspecified; U12.9!V: suspected adverse reactions to COVID-19 vaccine use, unspecified (post-COVIDvac condition).
  • Exclusion Criteria:
  • Any subsequent medical data that question the diagnosis of PCC or post-COVIDvac condition
  • Clinical picture can be explained by another underlying disease.
  • Pregnancy

Trial Officials

Uta Behrends, Prof. Dr. med.

Principal Investigator

MRI Chronic Fatigue Center for Young People (MCFC), Children's Hospital, Technical University of Munich & Munich Municipal Hospital

About Technical University Of Munich

The Technical University of Munich (TUM) is a leading research institution in Germany, renowned for its commitment to excellence in education, innovation, and technology transfer. With a strong emphasis on interdisciplinary collaboration, TUM fosters advancements in various fields, including medicine and life sciences. The university actively engages in clinical research, aiming to translate scientific discoveries into practical applications that improve patient outcomes. Through its state-of-the-art facilities and a network of partnerships with hospitals and industry, TUM is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and contribute significantly to the advancement of healthcare.

Locations

München, , Germany

Munich, Bavaria, Germany

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials